Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tsai, Shih Hung ^a   Huang, Po Hsun ^b,c   Hsu, Yu Juei ^a   Peng, Yi Jen ^a   Lee, Chien Hsing ^a   Wang, Jen Chun ^a,b   Chen, Jaw Wen ^b,c   Lin, Shing Jong ^b,c  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE;

ABDOMINAL AORTIC ANEURYSM; ANIMAL; BIOSYNTHESIS; CELL LINE; DISEASE MODEL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT;

EID: 84976886504     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28612     Document Type: Article

References (73)

1. Hirsch, A. T. et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113, e463-654, doi: 10.1161/circulationaha.106.174526 (2006).
2. Sakalihasan, N., Limet, R., Defawe, O. D. Abdominal aortic aneurysm. Lancet 365, 1577-1589, doi: 10.1016/s0140-6736(05)66459-8 (2005).
3. Sidloff, D. et al. Aneurysm global epidemiology study: public health measures can further reduce abdominal aortic aneurysm mortality. Circulation 129, 747-753, doi: 10.1161/circulationaha.113.005457 (2014).
4. Cosford, P. A., Leng, G. C. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev. CD002945, doi: 10.1002/14651858.CD002945.pub2 (2007).
5. Ernst, C. B. Abdominal aortic aneurysm. N Engl J Med 328, 1167-1172, doi: 10.1056/NEJM199304223281607 (1993).
6. Baxter, B. T., Terrin, M. C., Dalman, R. L. Medical management of small abdominal aortic aneurysms. Circulation 117, 1883-1889, doi: 10.1161/CIRCULATIONAHA.107.735274 (2008).
7. McCormick, M. L., Gavrila, D., Weintraub, N. L. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 27, 461-469, doi: 10.1161/01.ATV.0000257552.94483.14 (2007).
8. Marinkovic, G. et al. Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Junterminal-N-kinase in endothelial cells. Arterioscler Thromb Vasc Biol 33, 2380-2388, doi: 10.1161/atvbaha.113.301394 (2013).
9. Tsai, S. H. et al. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCKdependent JNK and NF-kappaB pathway. Cardiovasc Res 100, 501-510, doi: 10.1093/cvr/cvt230 (2013).
10. Saito, T. et al. Importance of endothelial NF-kappaB signalling in vascular remodelling and aortic aneurysm formation. Cardiovasc Res 97, 106-114, doi: 10.1093/cvr/cvs298 (2013).
11. Zhang, Y. et al. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol 29, 1764-1771, doi: 10.1161/atvbaha.109.192609 (2009).
12. Seta, F., Cohen, R. A. The endothelium: paracrine mediator of aortic dissection. Circulation 129, 2629-2632, doi: 10.1161/circulationaha.114.010609 (2014).
13. Meijer, C. A. et al. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann Intern Med 159, 815-823 (2013).
14. Lederle, F. A. Abdominal aortic aneurysm: still no pill. Ann Intern Med 159, 852-853 (2013).
15. Kasivisvanathan, V. et al. Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target. Curr Vasc Pharmacol 9, 333-349 (2011).
16. Choke, E. et al. Hypoxia at the site of abdominal aortic aneurysm rupture is not associated with increased lactate. Ann N Y Acad Sci 1085, 306-310, doi: 10.1196/annals.1383.005 (2006).
17. Sawada, H. et al. Aortic Iron Overload With Oxidative Stress and Inflammation in Human and Murine Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol 16, 305586 (2015).
18. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29, 15-18, doi: 10.1053/sonc.2002.37263 (2002).
19. Folkman, J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333, 1757-1763, doi: 10.1056/NEJM199512283332608 (1995).
20. Voest, E. E. et al. Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87, 581-586 (1995).
21. Li, L., Frei, B. Iron Chelation Inhibits NF-? B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity. Arteriosclerosis, Thrombosis, and Vascular Biology 26, 2638-2643, doi: 10.1161/01. ATV.0000245820.34238.da (2006).
22. Xiao, H. et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 128, 632-642, doi: 10.1161/circulationaha.113.002714 (2013).
23. Daugherty, A., Manning, M. W., Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105, 1605-1612, doi: 10.1172/JCI7818 (2000).
24. Zhang, H. et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci USA 105, 19579-19586, doi: 10.1073/pnas.0809763105 (2008).
25. Yoshida, T. et al. Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization. Faseb j 24, 1759-1767, doi: 10.1096/fj.09-145664 (2010).
26. Gayed, B. A., O'Malley, K. J., Pilch, J., Wang, Z. Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors. Clin Transl Sci 5, 39-42, doi: 10.1111/j.1752-8062.2011.00376.x (2012).
27. Abud, E. M. et al. Digoxin inhibits development of hypoxic pulmonary hypertension in mice. Proc Natl Acad Sci USA 109, 1239-1244, doi: 10.1073/pnas.1120385109 (2012).
28. Svensson, A., Azarbayjani, F., Backman, U., Matsumoto, T., Christofferson, R. Digoxin inhibits neuroblastoma tumor growth in mice. Anticancer Res 25, 207-212 (2005).
29. National Research Council Committee for the Update of the Guide for the, C., Use of Laboratory, A. In Guide for the Care and Use of Laboratory Animals (National Academies Press (US) National Academy of Sciences, 2011).
30. Daugherty, A., Cassis, L. A., Lu, H. Complex pathologies of angiotensin II-induced abdominal aortic aneurysms. J Zhejiang Univ Sci B 12, 624-628, doi: 10.1631/jzus.B1101002 (2011).
31. Satoh, K. et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 15, 649-656, doi: 10.1038/nm.1958 (2009).
32. Thangarajah, H. et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA 106, 13505-13510, doi: 10.1073/pnas.0906670106 (2009).
33. Prins, P. A. et al. Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure. PLoS One 9, e84517, doi: 10.1371/journal.pone.0084517 (2014).
34. Wei, Z. et al. Inhibiting the Th17/IL-17A-Related Inflammatory Responses With Digoxin Confers Protection Against Experimental Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol, doi: 10.1161/atvbaha.114.304435 (2014).
35. Ahn, G. O., Brown, J. M. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13, 193-205, doi: 10.1016/j.ccr.2007.11.032 (2008).
36. Rizas, K. D., Ippagunta, N., Tilson, M. D. 3rd. Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol Rev 17, 201-210, doi: 10.1097/CRD.0b013e3181b04698 (2009).
37. Rodrigues, M. et al. VEGF secreted by hypoxic Muller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 62, 3863-3873, doi: 10.2337/db13-0014 (2013).
38. Jing, S. W. et al. HIF-1alpha contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression. Acta Med Okayama 66, 399-407 (2012).
39. Wang, Z. et al. Hypoxia-inducible factor-1alpha contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int 79, 300-310, doi: 10.1038/ki.2010.326 (2011).
40. Zhu, Q. et al. Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 58, 657-664, doi: 10.1161/hypertensionaha.111.177626 (2011).
41. Nakayama, T. et al. Role of macrophage-derived hypoxia-inducible factor (HIF)-1alpha as a mediator of vascular remodelling. Cardiovasc Res 99, 705-715, doi: 10.1093/cvr/cvt146 (2013).
42. Imanishi, M. et al. Smooth muscle cell-specific Hif-1alpha deficiency suppresses angiotensin II-induced vascular remodelling in mice. Cardiovasc Res 102, 460-468, doi: 10.1093/cvr/cvu061 (2014).
43. Kadl, A. et al. Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2. Free Radic Biol Med 51, 1903-1909, doi: 10.1016/j.freeradbiomed.2011.08.026 (2011).
44. Jiang, H. et al. Critical role of toll-like receptor 4 in hypoxia-inducible factor 1alpha activation during trauma/hemorrhagic shocky induced acute lung injury after lymph infusion in mice. Shock 42, 271-278, doi: 10.1097/shk.0000000000000212 (2014).
45. Ma, X. et al. alpha5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1alpha and VEGF expression in non-small cell lung cancer. Toxicol Appl Pharmacol 278, 172-179, doi: 10.1016/j.taap.2014.04.023 (2014).
46. Shi, D. et al. Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating alpha7AChR, ERK, HIF-1alpha and VEGF/PEDF signaling. PLoS One 7, e43898, doi: 10.1371/journal.pone.0043898 (2012).
47. Usui, F. et al. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm. Arterioscler Thromb Vasc Biol 35, 127-136, doi: 10.1161/atvbaha.114.303763 (2015).
48. Tanweer, O., Wilson, T. A., Metaxa, E., Riina, H. A., Meng, H. A comparative review of the hemodynamics and pathogenesis of cerebral and abdominal aortic aneurysms: lessons to learn from each other. J Cerebrovasc Endovasc Neurosurg 16, 335-349, doi: 10.7461/jcen.2014.16.4.335 (2014).
49. Dale, M. A., Ruhlman, M. K., Baxter, B. T. Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy. Arterioscler Thromb Vasc Biol 35, 1746-1755, doi: 10.1161/atvbaha.115.305269 (2015).
50. Kazi, M. et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 38, 1283-1292, doi: 10.1016/s0741 (2003).
51. Franck, G. et al. Reestablishment of the endothelial lining by endothelial cell therapy stabilizes experimental abdominal aortic aneurysms. Circulation 127, 1877-1887, doi: 10.1161/circulationaha.113.001677 (2013).
52. Kim, C. W. et al. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler Thromb Vasc Biol 34, 1412-1421, doi: 10.1161/atvbaha.113.303134 (2014).
53. Choke, E. et al. Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. J Vasc Surg 52, 159-166 e151, doi: 10.1016/j.jvs.2010.02.015 (2010).
54. Matsumoto, T. et al. Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: Role of the Akt pathway and the ERK/Bim axis. Arthritis & Rheumatism 63, 3908-3917, doi: 10.1002/art.30646 (2011).
55. Sawada, H. et al. Aortic iron overload with oxidative stress and inflammation in human and murine abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 35, 1507-1514, doi: 10.1161/atvbaha.115.305586 (2015).
56. Englesbe, M. J., Wu, A. H., Clowes, A. W., Zierler, R. E. The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients. J Vasc Surg 37, 27-31, doi: 10.1067/mva.2003.57 (2003).
57. Lindeman, J. H., Rabelink, T. J., van Bockel, J. H. Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde? Circulation 124, e463-465, doi: 10.1161/circulationaha.110.008573 (2011).
58. Daniel, D., Susal, C., Kopp, B., Opelz, G., Terness, P. Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives. Int Immunopharmacol 3, 1791-1801, doi: 10.1016/j.intimp.2003.08.004 (2003).
59. Li, G. et al. Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-kappaB/HIF-1alpha pathway. Mol Immunol 53, 227-236 (2013).
60. Gupta, P. K. et al. Postdischarge outcomes after endovascular abdominal aortic aneurysm repair. J Vasc Surg 59, 903-908, doi: 10.1016/j.jvs.2013.10.057 (2014).
61. Dua, A., Algodi, M. M., Furlough, C., Ray, H., Desai, S. S. Development of a scoring system to estimate mortality in abdominal aortic aneurysms management. Vascular, doi: 10.1177/1708538114563825 (2014).
62. Schlosser, F. J. et al. Mortality after hospital admission for ruptured abdominal aortic aneurysm. Ann Vasc Surg 24, 1125-1132, doi: 10.1016/j.avsg.2010.07.010 (2010).
63. Jagielska, J., Salguero, G., Schieffer, B., Bavendiek, U. Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis? Atherosclerosis 206, 390-396, doi: 10.1016/j. atherosclerosis.2009.03.019 (2009).
64. Barchiesi, F. et al. Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension 56, 964-972, doi: 10.1161/hypertensionaha.110.152298 (2010).
65. Schaible, E. V. et al. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1alpha response after traumatic brain injury in mice. J Neurochem 129, 940-954, doi: 10.1111/jnc.12708 (2014).
66. Kurokawa, A. et al. 2-Methoxyestradiol reduces monocyte adhesion to aortic endothelial cells in ovariectomized rats. Endocr J 54, 1027-1031 (2007).
67. Bourghardt, J. et al. The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology 148, 4128-4132, doi: 10.1210/en.2007-0259 (2007).
68. Harrison, M. R. et al. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal(R) dispersion (NCD) in patients with taxanerefractory, metastatic castrate-resistant prostate cancer (CRPC). Invest New Drugs 29, 1465-1474, doi: 10.1007/s10637-010-9455-x (2011).
69. Bruce, J. Y. et al. A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate. Invest New Drugs 30, 794-802, doi: 10.1007/s10637-010-9618-9 (2012).
70. Kulke, M. H. et al. A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors. Cancer Chemother Pharmacol 68, 293-300, doi: 10.1007/s00280-010-1478-7 (2011).
71. Huang, Y. et al. Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alpha-dependent function. Proc Natl Acad Sci USA 109, 17478-17483, doi: 10.1073/pnas.1209281109 (2012).
72. Grigoryants, V. et al. Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms. J Vasc Surg 41, 108-114, doi: 10.1016/j.jvs.2004.09.033 (2005).
73. Yamawaki-Ogata, A. et al. A doxycycline loaded, controlled-release, biodegradable fiber for the treatment of aortic aneurysms. Biomaterials 31, 9554-9564, doi: 10.1016/j.biomaterials.2010.08.069 (2010).